Pre-operative chemotherapy with oral Tegafur-Uracil and leucovorin for rectal cancer (vol 89, pg 256, 2005)

被引：0
|
作者：
Kauh, J [1 ]
Johnstone, P [1 ]
机构：
[1] Emory Univ, Sch Med, Atlanta, GA 30322 USA
来源：
JOURNAL OF SURGICAL ONCOLOGY | 2005年 / 90卷 / 02期
关键词：
D O I：
10.1002/jso.20262
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：106 / 107
页数：2
相关论文
共 50 条
  • [31] Efficacy and short-term outcomes of preoperative chemoradiotherapy with intermittent oral tegafur-uracil plus leucovorin in Japanese rectal cancer patients: a single center experience retrospective analysis (vol 15, 112, 2017)
    Nakagawa, Ryosuke
    Inoue, Yuji
    Ohki, Takeshi
    Kaneko, Yuka
    Maeda, Fumi
    Yamamoto, Masakazu
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2017, 15
  • [32] Erratum to: Efficacy and short-term outcomes of preoperative chemoradiotherapy with intermittent oral tegafur-uracil plus leucovorin in Japanese rectal cancer patients: a single center experience retrospective analysis
    Ryosuke Nakagawa
    Yuji Inoue
    Takeshi Ohki
    Yuka Kaneko
    Fumi Maeda
    Masakazu Yamamoto
    World Journal of Surgical Oncology, 15
  • [33] Pre-operative chemoradiotherapy with UFT and Leucovorin in patients with advanced rectal cancer: A phase II study
    Giralt, Jordi
    Tabernero, Josep
    Navalpotro, Begona
    Capdevila, Jaume
    Espin, Eloi
    Casado, Esther
    Manes, Anabel
    Landolfi, Stefania
    Sanchez-Garcia, Jose Luis
    de Torres, Ines
    Armengol, Manel
    RADIOTHERAPY AND ONCOLOGY, 2008, 89 (03) : 263 - 269
  • [34] RELATIONSHIP BETWEEN MRNA EXPRESSION LEVELS AND CLINICAL EFFICACY OF ORAL URACIL AND TEGAFUR/LEUCOVORIN CHEMOTHERAPY IN PATIENTS WITH COLORECTAL CANCER
    Sadahiro, S.
    Suzuki, T.
    Maeda, Y.
    Tanaka, A.
    Okada, K.
    Ogoshi, K.
    Kamijo, A.
    ANNALS OF ONCOLOGY, 2010, 21 : 216 - 216
  • [35] The Efficacy of Oral Tegafur-Uracil as Maintenance Therapy Following Intravenous 5-Fluorouracil Chemotherapy in Stage III Colon Cancer
    Hong, Kwang Dae
    Lee, Sun Il
    Moon, Hong Young
    HEPATO-GASTROENTEROLOGY, 2012, 59 (113) : 104 - 107
  • [36] Health-Related Quality of Life During Postoperative Chemoradiotherapy with Oral Uracil-Tegafur and Leucovorin in Rectal Cancer Patients
    Ozgen, Zerrin
    Ozden, Sevgi
    Dane, Faysal
    Atasoy, Beste M.
    Akgunt, Zuleyha
    Yumuk, P. Fulden
    Mayadagli, Alpaslan
    Turhal, N. Serdar
    Abacioglu, Ufuk
    HEPATO-GASTROENTEROLOGY, 2013, 60 (123) : 533 - 537
  • [37] Reply to "The impact of adding mitomycin-C to radiotherapy plus oral tegafur-uracil (CCRT) on advanced-stage rectal cancer?"
    Wang, Ling-Wei
    Liu, Yu-Shih
    Jiang, Jeng-Kai
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2023, 86 (02) : 257 - 257
  • [38] Pre-operative chemoradiotherapy with oral capecitabine in locally advanced, resectable rectal cancer
    Korkolis, Dimitris P.
    Boskos, Christos S.
    Plataniotis, George D.
    Gontikakis, Emmanuel
    Karaitianos, Ioannis J.
    Avgerinos, Konstantinos
    Katopodi, Aggeliki
    Xinopoulos, Dimitris
    Dimitroulopoulos, Dimitris
    Beroukas, Konstantinos
    Vassilopoulos, Perikles P.
    ANTICANCER RESEARCH, 2007, 27 (1B) : 541 - 545
  • [39] Phase H study of first line chemotherapy with tegafur/uracil and oral leucovorin in elderly patients with advanced or metastatic colorectal cancer
    Murata, Kohei
    Yamamoto, Hirofumi
    Fukunaga, Mutsumi
    Kato, Takeshi
    Ohnishi, Tadashi
    Uemura, Yoshio
    Ohta, Hirofumi
    Kimura, Fumihiko
    Ohue, Masayuki
    Nezu, Riichiro
    Sekimoto, Mitsugu
    Ikeda, Masataka
    Mizushima, Tsunekazu
    Doki, Yuichiro
    Mori, Masaki
    CANCER RESEARCH, 2013, 73 (08)
  • [40] Clinical compliance with an oral uracil/tegafur (UFT) plus leucovorin (LV) regimen as adjuvant chemotherapy in Japanese colorectal cancer patients
    Makoto Meguro
    Tomohisa Furuhata
    Kenji Okita
    Toshihiko Nishidate
    Gentaro Ishiyama
    Yuji Iwayama
    Yasutoshi Kimura
    Toru Mizuguchi
    Koichi Hirata
    International Journal of Clinical Oncology, 2009, 14 : 402 - 407
12345